Bayer Will Appeal India Compulsory Licence On Its Cancer Drug
German pharmaceutical manufacturer Bayer has announced it will appeal yesterday's ruling in India that upheld a compulsory licence on one of its drugs.
Original news and analysis on international IP policy
German pharmaceutical manufacturer Bayer has announced it will appeal yesterday's ruling in India that upheld a compulsory licence on one of its drugs.
New Delhi - India’s Intellectual Property Appellate Board (IPAB) today upheld the country’s first compulsory licence on a pharmaceutical product. The much-awaited verdict by Justice (Ms) Prabha Sridevan upholds the compulsory licence issued to Hyderabad-based Natco Pharma Ltd, an Indian generic drug manufacturer, which sells a much cheaper version of German pharmaceutical company Bayer AG's kidney and liver cancer drug Nexavar in the market.
Nick Ashton-Hart writes: Some of you may have noticed that the ICT sector trade association that I represent in Geneva, the Computer and Communication Industry Association (CCIA), has endorsed a bid by the world’s Least Developed Countries (LDC’s) to remove any specific deadline for full compliance with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement.
The Medicines Patent Pool has announced a ground-breaking collaboration with a private sector joint venture that it said will facilitate greater availability of critical medicines for children with HIV worldwide. The announcement caused a wave of positive reactions across the public health community, with many hoping for more in the future.
With the threat of suspension of work looming, the World Intellectual Property Organization Standing Committee of the Law of Patents (SCP) agreed to a minimal programme of work, which includes exceptions and limitations to patent rights, quality of patents, and patents and health. Delegates made significant concessions on all sides, but the Africa Group expressed particular disappointment in the limited commitment to work on the patents and health topic.
Johannesburg, South Africa - Africa is still held captive by colonial borders and has failed to collectively leverage benefit-sharing agreements that result from multinationals’commercial pursuit of indigenous knowledge, said speakers at the Africa IP conference this week.
The role of intellectual property in a wide range of public health challenges - access to medicines, vaccine prices, procurement strategies, and research for diseases of the poor - is a focal point in 2013 cutting across national, regional, and international policymaking.
As the World Intellectual Property Organization’s patent law committee grapples with starkly differing positions on the topic of patents and health, the secretariats of WIPO, the World Health Organization and World Trade Organization presented to members how their first trilateral study on access to medical technologies and innovation could be used as an effective resource. While the secretariats emphasised the neutral, informative nature of the book, some members pointed to a need for greater analysis of the challenges developing countries face when trying to use patent flexibilities for access to medicines.
Johannesburg, South Africa -- The start of the Africa IP conference was the scene of a surprise protest action by Treatment Action Campaign health activists who ambushed the stage as South African Trade and Industry Minister Rob Davies was about to welcome delegates to the three-day conference.
European talks aimed at dragging copyright law into the digital age are not likely to produce results any time soon because of resistance from rights holders and political manoeuvring in the European Commission, players from the internet service provider and consumer sectors say. But the Commission said while it's true that changes could take several years, there will be regulation if needed.
The major recording industry association has released its annual report for 2012, announcing a 9 per cent increase in revenues from digital sales of music, with licensed music services on the rise. It also said it benefits most in countries where internet service providers have worked to drive down use of unauthorised music download sites.
The United Kingdom government has announced a change to the UK Patents Act that it says will help keep the country’s life sciences industry at the forefront of innovation by removing certain risks of drug development companies infringing patents.